| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.009 |